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Case Report__.____________________________________________ _ _ _ ___ ____
F. C. H enny , Ch. J. J. M ulder, A . S. L am pe, J. W . M. van d e r M eer
Branhamella catarrhalis Septicaemia in a Granulocytopenic Patient
Summary: A patient with acute leukaemia developed a 
maxillary sinusitis and septicaemia with Branhamella 
catarrhalis during the period of bone marrow hypopla­
sia. One blood culture also grew Staphylococcus 
aureus. In the same period, the patient developed 
tender red skin lesions and disseminated intra-vascular 
coagulation. The patient recovered when therapy with 
high dosages of amoxicillin was instituted. At the same 
time, however, the bone marrow recovered.
Zusammenfassung: Branhamella catarrhalis-Septik- 
ämie bei einem granulozytopenischen Patienten. Bei 
einem Patienten mit akuter Leukämie trat während 
der Phase der Knochenmarksdepression eine Sinusitis 
maxillaris und Septikämie durch Branhamella catar­
rhalis auf. In einer Blutkultur wuchs auch Staphylococ- 
cus aureus. In der gleichen Phase entwickelten sich bei 
dem Patienten weiche gerötete Hautläsionen und eine 
disseminierte intravasale Gerinnung. Unter hohen Do­
sen Amoxicillin erholte sich der Patient, gleichzeitig 
regenerierte auch das Knochenmark.
Introduction
Branhamella catarrhalis (former name: Neisseria catar­
rhalis) is a gram-negative diplococcus which occurs as a 
commensal in the upper respiratory tract. The organism 
may cause acute, often mild and self-limiting infections 
such as otitis media, maxillary sinusitis and lower respira­
tory tract infections (1, 2). Recently, however, B. catar­
rhalis has been reported as the etiologic agent of serious 
infections, especially in the immuno and myelo-suppress- 
ed host (3-9). The present paper reports a case of 
septicaemia in a leukaemic patient.
Case Report
A 24-year-old woman was admitted because of acute myeloblas- 
tic leukaemia (AML) in relapse. The AML had been diagnosed 
six months before, and administration of daunorubicine, vincris­
tine and cytosine arabinoside had been followed by a remission. 
On examination there were no abnormalities. Laboratory inves­
tigations: Hb: 8.9 mmol/1; WBC: 37x 109/1 with 4.2xl09/l granu­
locytes and 85% blast cells; platelet count: 7.0xl09/l. Further 
laboratory studies were normal. Chest and sinus radiographs 
were normal. Under protective isolation and oral antibiotic 
prophylaxis consisting of neomycin, polymyxin B, amphotericin 
B and nalidixic acid (SAM regimen) (10), intermediate dose cy­
tosine arabinoside and daunorubicine (11) was started. During 
the period of pancytopenia she developed a temperature of 
39° C. Physical examination revealed only a nasopharyngitis and
Figure 1: Tender red subcutaneous nodules on the legs.
bacteriological investigations showed no abnorm alities. The 
tem perature returned to norm al w ithout systemic antibiotics.
A week later, still pancytopenic, she had a chill after a transfus­
ion and developed diarrhoea. She appeared  ill with a tem pera­
ture of 39° C. T he chest X-ray was norm al, but sinus X -ray films 
disclosed an air fluid level in the right m axillary sinus. B lood cui* 
tures w ere taken  and because septicaem ia was suspected , tre a t­
ment with intravenous tobram ycin and cefam andole (4x1 g) 
was started. D uring the next four days her tem pera tu re  rem ain­
ed around 39° C and repeated  exam inations show ed no  abnor­
malities.
On the fifth day tender red subcutaneous nodules (Figure 1) 
were found on the arms and legs. C ultures from the maxillary si­
nus could not be taken because of dissem inated intravascular 
coagulation (D1C) and profound throm bocytopenia . O n the 
same day three blood cultures w ere reported  to be positive for 
B. catarrhalis, sensitive to amoxicillin and  to cefam andole, in­
term ediate to tobram ycin and resistant to sulfam ethoxazole and 
trim ethoprim  (disk diffusion technique). O ne of the  blood cul­
tures also yielded Staphylococcus aureus, as did one  stool spec­
imen. A ntibiotic trea tm en t was changed to amoxicillin (6 x  2 g) 
and cloxacillin (6 x 1  g) intravenously. W ithin the next five days 
the bone marrow recovered, the skin lesions cleared and the 
tem perature  returned to norm al. A t this tim e an asp irate  from 
the maxillary sinus showed many leucocytes, but no  bacteria in 
the G ram  stain; cultures rem ained sterile. Amoxicillin and clo­
xacillin w ere continued for twelve days. T h e  patient experienced 
ano ther remission and was discharged in good condition.
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Discussion
This report documents the pathogenicity of B. catarrhalis 
in a compromised host. Previously, this agent was recog­
nised as the cause of otitis media (1), maxillary sinusitis 
(2), pneumonia (3, 7), meningitis with septicaemia (4, 6) 
and endocarditis (8, 9). Our patient had subcutaneous no­
dules giving the impression of a disseminated infection. 
Since the lesions were not punctured for culture, we can­
not prove that they represented metastatic lesions with B. 
catarrhalis. The skin lesions did not resemble the skin le­
sions of meningococcal septicaemia which have also been 
reported in B. catarrhalis meningitis (6). As a gram-ne­
gative microorganism, B. catarrhalis produces endotoxin 
and this might explain the DIC. Although the B. catarrha­
lis strain was sensitive in vitro to cefamandole, our patient 
did not respond until a high dose of amoxicillin was given.
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At the same time, however, the bone marrow recovered. 
Since organisms like B. catarrhalis are not eradicated with 
the oral non-absorbable antibiotics used (10), infections 
with such microorganisms can occur.
Prophylaxis with co-trimoxazole (12) most probably 
would not have prevented this infection either, since the 
microorganism was co-trimoxazole-resistant. Our case re­
port underlines the experience in previous reports that B 
catarrhalis is an opportunistic pathogen that may cause 
serious systemic infections in the compromised host.
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